FMC (FMC) Form 144 Notice: 1,510 Shares from Restricted Vesting
Rhea-AI Filing Summary
Form 144 notice for FMC Corporation (FMC) reports a proposed sale of 1,510 common shares held in a brokerage account at Fidelity with an aggregate market value of $56,609.90. The shares were acquired on 09/27/2024 through restricted stock vesting as compensation, and the filer indicates an approximate sale date of 08/18/2025 on the NYSE. The filing shows 124,911,586 shares outstanding for context. No securities were reported sold by the filer in the past three months. The notice includes the standard representation that the seller has no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
Routine insider sale notice; economically immaterial relative to company size.
The Form 144 documents an insider-originated sale of 1,510 shares valued at roughly $56.6k, originating from restricted stock vesting used as compensation. Against the stated 124.9 million shares outstanding, this quantity is negligible and unlikely to affect supply-demand dynamics or share price. The filing is procedural, enabling compliance with Rule 144 for an anticipated sale on the NYSE. There are no reported sales in the prior three months, which suggests this is an isolated planned disposition rather than part of an active selling pattern.
Compliance-focused disclosure; preserves transparency on insider compensation monetization.
From a governance perspective, the filing meets disclosure obligations by identifying the nature of acquisition (restricted stock vesting), brokerage firm, and planned sale timing. The filer’s certification about lack of undisclosed material information is standard. The modest size and compensation origin reduce concerns about opportunistic insider trading, and the absence of recent sales limits inference of sustained insider offloading. This is a routine compliance communication rather than a governance red flag.